Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Clinical outcome measures in multiple sclerosis.
A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial.
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Invisible Killers.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Seronegative neuromyelitis optica after cardiac transplantation.
BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity.
Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.
Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
Cerebral tumefactive demyelinating lesions.
Electron microscopy of myelin: Structure preservation by high-pressure freezing.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Advances in myelin imaging with potential clinical application to pediatric imaging.
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.
Multiple sclerosis and pregnancy: a comparison study.
Blinded and unblinded internal pilot study designs for clinical trials with count data.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »